amiodarone has been researched along with Hemochromatosis in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 5.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 1.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yalçinkaya, S | 1 |
| Kumbasar, SD | 1 |
| Semiz, E | 1 |
| Tosun, Z | 1 |
| Paksoy, N | 1 |
1 other study available for amiodarone and Hemochromatosis
| Article | Year |
|---|---|
Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiomyopathies; Electrocardiography; Hemoc | 1997 |